Evidence map›Paper›PMID 41511688›Full record

ArticleMolecular diversity2026

FRAIL: fragment-based reinforcement learning for molecular design and benchmarking on fatty acid amide hydrolase 1 (FAAH-1).

Manh-Tu Luong, Khanh Huyen Thi Pham, Nhat-Hai Nguyen, Van-Tuan Le, Phu Tran Vinh Pham, Tan Khanh Nguyen, Thi-Thu Nguyen

Abstract read
PubMed Publisher
In one paragraph

Article in Molecular diversity, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Manh-Tu Luong *Institute for AI Innovation and Societal Impact (AI4LIFE), Hanoi University of Science and Technology, Hanoi, Vietnam.ORCID http://orcid.org/0009-0000-0872-8352
Khanh Huyen Thi PhamCollege of Pharmacy and Integrated Research Institute for Drug Development, Dongguk University-Seoul, Goyang-si, Gyeonggi-do, 10326, Republic of Korea.ORCID http://orcid.org/0000-0003-3240-2699
Nhat-Hai NguyenInstitute for AI Innovation and Societal Impact (AI4LIFE), Hanoi University of Science and Technology, Hanoi, Vietnam.ORCID http://orcid.org/0000-0002-7724-3612
Van-Tuan LeInstitute for AI Innovation and Societal Impact (AI4LIFE), Hanoi University of Science and Technology, Hanoi, Vietnam.
Phu Tran Vinh PhamVN-UK Institute for Research and Executive Education, The University of Danang, Danang, Vietnam.ORCID http://orcid.org/0000-0002-4359-4924
Tan Khanh NguyenScientific Management Department, Dong A University, Danang, Vietnam. khanhnt2501@gmail.com.ORCID http://orcid.org/0000-0002-6558-273X
Thi-Thu NguyenInstitute for AI Innovation and Societal Impact (AI4LIFE), Hanoi University of Science and Technology, Hanoi, Vietnam. thithu.nguyen6@hust.edu.vn.ORCID http://orcid.org/0000-0003-2425-7356

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

We propose FRAIL (Fragment-based Reinforcement Learning for Inhibitors), a generative AI framework that integrates fragment-based molecular design, multi- objective reinforcement learning, and molecular modeling to accelerate inhibitor discovery. Several deep generative models were fine-tuned on FAAH-1 (Fatty Acid Amide Hydrolase 1)-specific dataset and systematically benchmarked, with the best-performing model incorporated into FRAIL. The framework employs a customized reward function that jointly optimizes physicochemical properties and predicted bioactivity (pIC

Indexed as

AmidohydrolasesDrug DesignEnzyme InhibitorsBenchmarkingFatty Acid Amide HydrolasesGenerative Artificial IntelligenceModels, MolecularReinforcement Machine LearningAmidohydrolasesEnzyme InhibitorsFatty Acid Amide HydrolasesFAAH-1Fragment-based designGenerative AIMolecular modelling

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.